ebomi
Colour theme
Sign in
Insider · CIK 0001249675

Perceptive Life Sciences Master Fund Ltd

CIK 0001249675 Name as filed on the most recent filing

Filed as Perceptive Life Sciences Master Fund Ltd (318)

817 transaction lines · from 318 filings · filed 2003-08-08 to 2025-11-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-12-23 P, Open-market purchase Athenex, Inc.ATNX 2,191,289, acquired Open Form 4 filing 0000899243-19-030019
2019-12-20 P, Open-market purchase Athenex, Inc.ATNX 2,677,013, acquired Open Form 4 filing 0000899243-19-030019
2019-12-19 P, Open-market purchase Athenex, Inc.ATNX 2 lines 3,635,484, acquired Open Form 4 filing 0000899243-19-030019
2019-11-18 P, Open-market purchase Kadmon Holdings, Inc.KDMN 4,999,999, acquired Open Form 4 filing 0000899243-19-027464
2019-11-15 P, Open-market purchase Agile Therapeutics IncAGRX 3 lines 8,940,812, acquired Open Form 4 filing 0000899243-19-027548
2019-11-14 P, Open-market purchase Agile Therapeutics IncAGRX 735,175, acquired Open Form 4 filing 0000899243-19-027548
2019-11-07 P, Open-market purchase Quotient LtdQTNT 17,500,000, acquired Open Form 4 filing 0000899243-19-027085
2019-10-29 S, Open-market sale Agile Therapeutics IncAGRX 334,528, disposed Open Form 4 filing 0000899243-19-026431
2019-10-28 S, Open-market sale Agile Therapeutics IncAGRX 1,945,828, disposed Open Form 4 filing 0000899243-19-026360
2019-10-17 P, Open-market purchase Athenex, Inc.ATNX 546,500, acquired Open Form 4 filing 0000899243-19-025811
2019-10-16 P, Open-market purchase Athenex, Inc.ATNX 691,714, acquired Open Form 4 filing 0000899243-19-025785
2019-09-23 P, Open-market purchase VBI Vaccines Inc/BCVBIV 10,000,000, acquired Open Form 4 filing 0000899243-19-024191
2019-09-16 P, Open-market purchase Athenex, Inc.ATNX 407,400, acquired Open Form 4 filing 0000899243-19-023847
2019-09-13 P, Open-market purchase Athenex, Inc.ATNX 805,056, acquired Open Form 4 filing 0000899243-19-023675
2019-09-12 P, Open-market purchase Athenex, Inc.ATNX 190,855, acquired Open Form 4 filing 0000899243-19-023675
2019-08-16 P, Open-market purchase Athenex, Inc.ATNX 299,200, acquired Open Form 4 filing 0000899243-19-021988
2019-08-15 P, Open-market purchase Athenex, Inc.ATNX 450,000, acquired Open Form 4 filing 0000899243-19-021988
2019-08-12 P, Open-market purchase MeiraGTx Holdings plcMGTX 9,999,979, acquired Open Form 4 filing 0000899243-19-022128
2019-08-08 P, Open-market purchase Athenex, Inc.ATNX 472,800, acquired Open Form 4 filing 0000899243-19-021483
2019-08-07 P, Open-market purchase Athenex, Inc.ATNX 4 lines 10,576,251, acquired Open Form 4 filing 0000899243-19-021483
2019-08-06 P, Open-market purchase Agile Therapeutics IncAGRX 2,185,000, acquired Open Form 4 filing 0000899243-19-026360
2019-07-25 P, Open-market purchase Solid Biosciences Inc.SLDB 13,125,002, acquired Open Form 4 filing 0001012975-19-000502
2019-07-11 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 715,410, acquired Open Form 4 filing 0000899243-19-019495
2019-07-10 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 208,659, acquired Open Form 4 filing 0000899243-19-019495
2019-07-09 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 495,543, acquired Open Form 4 filing 0000899243-19-019495
2019-07-05 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 823,000, acquired Open Form 4 filing 0000899243-19-019402
2019-07-03 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 28,422, acquired Open Form 4 filing 0000899243-19-019223
2019-07-02 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 11,540, acquired Open Form 4 filing 0000899243-19-019223
2019-07-01 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 258,043, acquired Open Form 4 filing 0000899243-19-019223
2019-06-28 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 2 lines 1,417,085, acquired Open Form 4 filing 0000899243-19-018731
2019-06-27 P, Open-market purchase Dova Pharmaceuticals Inc.DOVA 2 lines 4,286,124, acquired Open Form 4 filing 0000899243-19-018731
2019-06-27 P, Open-market purchase Motus GI Holdings, Inc.MOTS 3,000,000, acquired Open Form 4 filing 0000899243-19-018729
2019-06-25 P, Open-market purchase Athenex, Inc.ATNX 26,746, acquired Open Form 4 filing 0000899243-19-021483
2019-06-24 P, Open-market purchase Athenex, Inc.ATNX 372,069, acquired Open Form 4 filing 0000899243-19-021483
2019-06-21 P, Open-market purchase Athenex, Inc.ATNX 411,853, acquired Open Form 4 filing 0000899243-19-021483
2019-06-18 P, Open-market purchase Athenex, Inc.ATNX 899,656, acquired Open Form 4 filing 0000899243-19-017728
2019-06-18 P, Open-market purchase VBI Vaccines Inc/BCVBIV 650,000, acquired Open Form 4 filing 0001012975-19-000447
2019-06-17 P, Open-market purchase VBI Vaccines Inc/BCVBIV 618,000, acquired Open Form 4 filing 0001012975-19-000443
2019-06-17 P, Open-market purchase Athenex, Inc.ATNX 2,332,200, acquired Open Form 4 filing 0000899243-19-017492
2019-06-14 P, Open-market purchase Athenex, Inc.ATNX 5,736,690, acquired Open Form 4 filing 0000899243-19-017348
2019-06-13 P, Open-market purchase Athenex, Inc.ATNX 1,290,856, acquired Open Form 4 filing 0000899243-19-017244
2019-05-21 P, Open-market purchase Adma Biologics, Inc.ADMA 16,000,000, acquired Open Form 4 filing 0000899243-19-014466

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. PERCEPTIVE LIFE SCIENCES MASTER FUND LTD, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001249675

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.